This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Arizona. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Makiko Watanabe: Innovator in SARS-CoV-2 Testing
Introduction
Makiko Watanabe is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of SARS-CoV-2 antibodies. Her innovative work has implications for public health and disease management.
Latest Patents
Watanabe holds a patent for a test system designed to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This patent, titled "Serological assays for SARS-CoV-2," includes a test system comprising SARS-CoV-2 receptor binding domain (RBD) antigen, SARS-CoV-2 S2 antigen, and binding moieties that specifically bind to human IgG, human IgA, and human IgM. The methods provided in her patent enable the detection of SARS-CoV-2 antibodies in a sample using this test system. She has 1 patent to her name.
Career Highlights
Watanabe is affiliated with the University of Arizona, where she conducts her research and development work. Her role at the university allows her to collaborate with other experts in the field and contribute to advancements in medical technology.
Collaborations
Some of her notable coworkers include Ryan Sprissler and Tyler Ripperger. Their collaborative efforts enhance the research environment and foster innovation in their projects.
Conclusion
Makiko Watanabe's contributions to the field of SARS-CoV-2 testing exemplify her dedication to improving public health through innovative solutions. Her work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile